570.00DKK-4.20%Mkt Cap: 23.57M DKKP/E: —Last update: 2026-06-01
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 202…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap23.57M DKK
Enterprise Value8.89M DKK
Revenue (TTM)309.00K DKK
Gross Profit309.00K DKK
Net Income (TTM)-859.00K DKK
Revenue/Share7.408 DKK
Last Price570.00 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1
CountryDK
SectorHealthcare
IndustryBiotechnology
ISINDK0062502894
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue28.78
P/S79.62
P/B1.35
EPS (TTM)-21.00
EPS (Forward)—
52W Range
550.003% of range1300.00
52W High1300.00 DKK
52W Low550.00 DKK
Profitability
Gross Margin100.00%
Oper. Margin-309.06%
EBITDA Margin0.00%
Profit Margin-277.99%
ROE-4.67%
ROA-4.40%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.14M DKK
CapEx (TTM)—
FCF Margin-1492.80%
FCF Yield-19.57%
Net Debt-15.93M DKK
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio13.90
Quick Ratio13.90
Book Value/Sh440.88 DKK
Cash/Share381.79 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateDec 6, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.35K
Float16.78K
Insiders56.74%
Institutions5.86%
Technical
SMA 50624.10 (-8.7%)
SMA 200739.83 (-23.0%)
Beta0.14
S&P 52W Chg27.94%
Avg Vol (30d)7
Avg Vol (10d)12
Technical Indicators
RSI (14)42.5
MACD-12.0556
MACD Signal-4.3235
MACD Hist.-7.7321
BB Upper692.11 DKK
BB Middle630.25 DKK
BB Lower568.39 DKK
BB Width19.63%
ATR (14)22.73 DKK
Vol Ratio (20d)0.00x